Jessica T, MD, MS, AAHIVS

Columbia Infectious Diseases Doctor/Asst. Professor | Pianist & Violinist | Former Yale ID/World Bank Leadership in Global Health Fellow/Public Voices Fellow

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

My first Opinion piece, “Is There a Price and Time Limit on Human Justice, Freedom, and Dignity?”—an ode to my patients—was published in @Newsweek. I am a Public Voices Fellow with the @TheOpEdProject in partnership with @Yale.

https://t.co/vvMqZ3dMyh

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

The PURPOSE 1 HIV Prevention Clinical Trial demonstrates 100% efficacy of twice-yearly Lenacapavir as HIV Pre-exposure prophylaxis in women! https://t.co/imRr01OwDf

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

My Opinion piece, “Fighting Words in a COVID-19 Pandemic—Combating an Era of Denialism” was published in @Newsweek. I am a Public Voices Fellow with the @TheOpEdProject in partnership with
@Yale.

https://t.co/4Ba2uDbJT7

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

@Dr_AmyKacin @vcantosl

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

Our paper, "COVID-19 vaccine efficacy in participants with weakened immune systems from 4 randomized-controlled trials," was published in CID. https://t.co/VBTCFaCxWP

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

I'm playing violin (sound bite from rehearsal) in the @Yale Medical Symphony Orchestra Concert—ft. Jean Sibelius' Symphony 2 & Finlandia & Samuel Coleridge-Taylor's Petite Suite. Hope to see you there, Fri 7:30 pm at Harkness Auditorium!

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

https://t.co/lX3hcWvzun

[Yale Internal Medicine @YaleIMed]

During residency, @DrJessicaT spent 4 months in Rwanda & was captivated by the fascinating pathology behind infectious diseases.

Now Tuan is associate director of the Yale Antivirals and Vaccine Research Program Department of Internal Medicine.

More👇
https://t.co/uGn28JcQz2

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

https://t.co/hXikL3YsGg

[Contagion @Contagion_Live]

From our August issue, @DrJessicaT and @DrOnyemaOgbuagu look at the development of #HIV vaccines including their history and a review of the pipeline. #IDtwitter #MedTwitter

https://t.co/7GYA5Ovszj

[The Lancet HIV @TheLancetHIV]

First large multicentre phase 3b study shows non-inferiority of long-acting cabotegravir plus rilpivirine dosed every 2 months as a complete antiretroviral regimen vs. continued once-daily bictegravir, emtricitabine, and tenofovir alafenamide. #HIV #ART
https://t.co/sPv9lt6Dbz

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

Pitavastatin lowers Major Adverse Cardiovascular Event risk in people living with HIV (PLWH). Proud of our Yale research team's contribution & to be a REPRIEVE Study site PI. I know this study data will impact long-term care of PLWH https://t.co/TWOutFSM1s https://t.co/PIF8Q2ymCu

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

Doctors from all corners of the world & I flew to Peru’s Alexander von Humboldt Tropical Medicine Institute to learn from the Gorgas Advanced Course tropical medicine experts about how to manage patients with leprosy, leishmaniasis, paracoccidioidomycosis, dengue, verruga peruana, MDR-TB, etc. Thank you to the doctors & patients for sharing your collective wisdom & experience.

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

Living out my dream at the Gorgas Advanced Course in Clinical Tropical Medicine - Alexander von Humboldt Tropical Medicine Institute, Cayetano Heredia National Hospital - Lima, Peru

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

Exciting interim analysis results from the @reprievetrial, for which I am a site Principal Investigator:

Pitavastatin lowered Major Adverse Cardiovascular Event risk in people with HIV by 35% vs. placebo

https://t.co/MmirlLuaXG

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

@zeb_kayani @DOMSinaiNYC @IcahnMountSinai @MSH_MedChiefs @YaleMed Congratulations @zeb_kayani—they are lucky to have you!

[Jessica T, MD, MS, AAHIVS @DrJessicaT]

@LydiaBarakatMD Thank you for your support @LydiaBarakatMD!